Tech Company Financing Transactions
Kalidex Pharmaceuticals Funding Round
Kalidex Pharmaceuticals, based in Menlo Park, received $251 thousand from Frazier Healthcare Partners and private investors.
Transaction Overview
Company Name
Announced On
12/31/2010
Transaction Type
Venture Equity
Amount
$251,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
70 Willow Road 200
Menlo Park, CA 94025
USA
Menlo Park, CA 94025
USA
Phone
Website
Email Address
Not Recorded
Overview
Kalidex Pharmaceuticals, Inc is a privately held anti-infective company creating the next generation of quinolones to help address the global problem of emerging infections caused by MDR organisms.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Yigong Ge
Browse more venture capital transactions:
Prev: 12/31/2010: TimeSight Systems venture capital transaction
Next: 12/31/2010: NovaTorque venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. All VC database entries on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs